InflaRx, Inc.

Monoclonal antibody therapies against sepsis

(2008)

Location:
Jena, Germany

Management:
Niels C. Riedemann, CEO

UM Inventor(s):
Peter A. Ward

Funding parties:
Affentranger Associates, Beteiligungs-Management